Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

5.1%

13 terminated/withdrawn out of 254 trials

Success Rate

91.8%

+5.3% vs industry average

Late-Stage Pipeline

16%

40 trials in Phase 3/4

Results Transparency

3%

5 of 145 completed trials have results

Key Signals

26 recruiting5 with results11 terminated

Enrollment Performance

Analytics

N/A
67(37.0%)
Phase 2
54(29.8%)
Phase 3
24(13.3%)
Phase 1
19(10.5%)
Phase 4
16(8.8%)
Early Phase 1
1(0.6%)
181Total
N/A(67)
Phase 2(54)
Phase 3(24)
Phase 1(19)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (254)

Showing 20 of 254 trials
NCT06612515Recruiting

Vaccine-induced Immunity in Immunocompromised Patients

Role: lead

NCT06781710Completed

Analysis of the Epidemiology, Clinical Presentation and Therapy as Well as Therapy-associated Risk of Demyelination Syndrome in Patients With Profound Hyponatremia in the Emergency Department

Role: lead

NCT05709600Not ApplicableRecruiting

Dietary Interventions During Living Kidney Donations

Role: lead

NCT04985318Active Not Recruiting

Retrospective Analysis of the Efficiency of Caplacizumab in the Treatment of aTTP

Role: lead

NCT02497521Recruiting

The German ADPKD Tolvaptan Treatment Registry

Role: lead

NCT03381794Recruiting

The German Keratoplasty Registry of the German Ophthalmological Society (DOG)

Role: collaborator

NCT03652441Phase 2Completed

Consolidation Therapy With Brentuximab Vedotin After Allogeneic Stem Cell Transplantation for Relapsed or Refractory Hodgkin Lymphoma

Role: lead

NCT04656951Phase 2Active Not Recruiting

Daratumumab for First Line Treatment of Transplant-ineligible Myeloma Patients Followed by Daratumumab Re-treatment at First Relapse

Role: lead

NCT07280585Phase 3Recruiting

STOP-PKD: SGLT2-inhibition to Improve Prognosis in Polycystic Kidney Disease

Role: lead

NCT05975203Not ApplicableRecruiting

Continuous Delivery Room Skin-to-skin-study for Moderate and Late Preterm Infants

Role: lead

NCT06412653Phase 2Completed

Prospective Pilot Trial to Address Feasibility and Safety of Oral Zinc in GNAO1 Associated Disorders

Role: collaborator

NCT07326124Phase 3Not Yet Recruiting

Stratification and Treatment in Early Psychosis Study -ASSIST

Role: collaborator

NCT07297407Not ApplicableNot Yet Recruiting

Prevention-in-PD-Study

Role: collaborator

NCT04323904Recruiting

Hantavirus Registry - HantaReg

Role: lead

NCT04288674Recruiting

Leptospirosis Registry - LeptoScope

Role: lead

NCT04797091Completed

Kidney in Coronavirus Disease 2019 Registry

Role: lead

NCT06778564Phase 3Not Yet Recruiting

Stratification and Treatment in Early Psychosis Study - ENHANCE

Role: collaborator

NCT07255833Completed

Retrospective Analysis of ECG Changes and Arrhythmias in Patients With Profound Hyponatremia

Role: lead

NCT07000708Not ApplicableRecruiting

VITAL: Vaccination, Immunity, Time-restricted Eating, Aging and Lifestyle

Role: collaborator

NCT06408077Not ApplicableRecruiting

Regulation of Extracellular Sodium in End Stage Renal Disease Upon Volume and Electrolyte Challenges

Role: lead